Arrowstreet Capital, Limited Partnership Reduces $58M in Cencora, Inc. ($COR)
Key Points
- Arrowstreet Capital, Limited Partnership changed its Cencora, Inc. ($COR) stake by 16.5% last quarter, cutting to 1,042,002 shares worth $295.62 million.
- Wall Street's consensus rating on $COR is Buy and an average price target of $350.58.
- $COR last traded around $283.70.
Arrowstreet Capital, Limited Partnership reduced its position in Cencora, Inc. ($COR) by 16.5% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,042,002 shares of Cencora, Inc. after selling 205,966 shares during the quarter. Arrowstreet Capital, Limited Partnership's holdings in Cencora, Inc. were worth $295.62 million as of its most recent filing.
Cencora, Inc. ($COR) Stock
Cencora, Inc. Earnings
Cencora, Inc. Dividend
Analysts Set New Price Targets
About Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.